Company News in the Life Science Industry

»

Reset 

Re-Interventions Are Common in Long-Term Survivors of Childhood Heart Operation

PHILADELPHIA, Sept. 18, 2017 /PRNewswire-USNewswire/ -- Among patients who undergo childhood heart surgery for the severe birth defect single-ventricle disease, two-thirds of survivors require a surgical or catheter-based procedure within 20 years. Pediatric cardiology researchers note that doctors... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

$5.8 Million Awarded For Vaccine Engineering Will Use "Immune History" To Protect Against Bird Flu, A Collaboration Led By EpiVax

PROVIDENCE, R.I., Sept. 18, 2017 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") a pioneer in the fields of bioinformatics and immune engineering, today announced a new NIH-funded collaboration to develop a protective avian influenza A (H7N9) vaccine.

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  EpiVax

101 Antibody-Drug Conjugate Experts to Present at the Industry's Longest Standing & Most Comprehensive Antibody-Drug Conjugate Conference

SAN DIEGO, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Elsevier Launches New, Improved HESI Review and Testing Solution

ST. LOUIS, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Elsevier Inc. | Elsevier Inc. | Elsevier Inc., SciTech Connect

Sex and Aggression Controlled Separately in Female Animal Brains, But Overlap in Males

NEW YORK, Sept. 18, 2017 /PRNewswire-USNewswire/ -- Brain structures that control sexual and aggressive behavior in mice are wired differently in females than in males. This is the finding of a study led by scientists at NYU School of Medicine and published online Sept. 18 in Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  NYU Langone Medical Center | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

Crescita Therapeutics(TM) Reports Positive Topline Results of Phase 2 Clinical Trial for the Treatment of Plaque Psoriasis

MISSISSAUGA, ON, Sept. 18, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products today announced that it has received positive topline results... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Crescita Therapeutics Inc.

Multidisciplinary Association for Psychedelic Studies (MAPS) Selects Montrium's eTMF Platform as They Begin Phase 3 Studies of MDMA-assisted Psychotherapy for PTSD

MONTREAL, Sept. 18, 2017 /PRNewswire/ -- Montrium, a growing leader in Electronic Trial Master file solutions, today announced an exciting... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Montrium Inc

Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer

BASEL, Switzerland, Sept. 18, 2017 /PRNewswire/ -- Urovant Sciences, a global biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced the appointment of Keith A. Katkin as Chief Executive Officer.

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Roivant Sciences GmbH

Solon Eiendom ASA : Primary insider notification

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017

Merck Announces Recipients of the Grant for Growth Innovation 2017

DARMSTADT, Germany, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Merck KGaA | Merck Chemicals GmbH

Camurus Announces That FDA Grants Priority Review of NDA for Weekly and Monthly CAM2038 Buprenorphine Depots for Treatment of Opioid Use Disorder

LUND, Sweden, Sept. 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Camurus AB | Camurus AB

Web Briefing: Good Data Governance is Good Regulatory Compliance

Mundipharma to discuss the importance of MDM to address IDMP, GDPR

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Gastrointestinal Stents Market Size Worth $472.5 Million by 2025: Grand View Research, Inc.

SAN FRANCISCO, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Global Hepatitis Testing Markets to 2021

DUBLIN, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management

PHILADELPHIA and WAYNE, Pa., Sept. 18, 2017 /PRNewswire/ -- The National Lacrosse League (NLL), the largest men's professional indoor lacrosse league in North America, and Egalet... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Egalet Corporation

Breakfast Technical Briefing on Generic Drugs Stocks -- Mallinckrodt, Horizon Pharma, Mylan, and Neurocrine Biosciences

NEW YORK, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Neurocrine Biosciences, Inc.

Global Biomedical Sensors Market - Expected to Reach a Value of USD 18.4 Billion by 2022

DUBLIN, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Medical Research Stock Performance Review -- Agilent Technologies, Alere, Quintiles IMS, and Thermo Fisher Scientific

NEW YORK, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Capricor Therapeutics to Present Six-Month Results from the Randomized HOPE Trial of CAP-1002 in Duchenne Muscular Dystrophy in a Late Breaking Session of the World Muscle Society

LOS ANGELES, Sept. 18, 2017 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies for Duchenne muscular dystrophy (DMD) and other rare diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Capricor Therapeutics, Inc.

Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer

SAN DIEGO, Sept. 18, 2017 /PRNewswire/ -- Abide Therapeutics, a developer of innovative pharmaceuticals, announced today the appointment of Sapna Srivastava, Ph.D., to the position of Chief Financial and Strategy Officer. Dr.... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Abide Therapeutics Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 40,000 companies